Wu (2020)
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)
32220033
https://www.ncbi.nlm.nih.gov/pubmed/32220033
Patient characteristics
Age (>=65 years vs. <65 years)
COVID-19 (severe/critical)
Odds ratio: 16.320 (4.590-58.010) Univariate analysis

China

Retrospective observational study

Medical records

280

A total of 280 eligible COVID-19 patients were recruited from four hospitals in Jiangsu and Anhui Province, China.

Among the enrolled cases, the overall mean age was 43.12 years (SD 19.02). 84 patients (30.00%) were aged 50-64 years, which accounted for the highest proportion. The proportion of patients aged under 18 years, 18-24 years and 25-49 years were 12.50%, 5.00% and 27.86%, respectively. Moreover, 49 patients (17.50%) were mild type, 148 patients (52.86%) were moderate type, 75 patients (26.79%) were severe type and 8 patients (2.85%) were critically ill.

Median

0


COVID-19 (severe/critical)

83

Not defined


Patient characteristics

Age

none

<65 years

>=65 years


Odds ratio

16.320 (4.590-58.010)

No

Yes

No

Age, comorbidity, time from illness onset to antiviral treatment


none

Good

Yes